The probability that a newborn or a family member need a regenerative therapy withhigh donor-recipient compatibility is low, estimated at one per 20,000 inhabitants, butthe likelihood exists and, in these cases, access to such material can be of greatimportance to the patient.
The extraction of umbilical cord blood can only be done at the time immediatelyfollowing childbirth. The process of collecting cord blood is simple, painless andinvolves no risk or to the newborn or the mother.
The actual medical benefit of access to own stem cells, the patient or family member,is given to pathological conditions whose treatment requires a bone marrow transplant,the type of leukemia or lymphoma, certain metabolic disorders and someimmunodeficiencies genetic origin. Scientific progress, probably will in future cell therapy for other diseases where the organ or tissue regeneration is needed.
No comments:
Post a Comment